Omkar Pharmachem Ltd (532167) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532167 | NSE: | Pharmaceuticals & Drugs | Small Cap

Omkar Pharmachem Share Price

28.33 0.00 0.00%
as on 20-Oct'25 16:59

Omkar Pharmachem Ltd (532167) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532167 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Omkar Pharmachem

Based on:

M-Cap below 100cr DeciZen not available

Omkar Pharmachem stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
161.41
Market Cap:
28.6 Cr.
52-wk low:
25.5
52-wk high:
30.1

Is Omkar Pharmachem Ltd an attractive stock to invest in?

1. Is Omkar Pharmachem Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Omkar Pharmachem Ltd is a below average quality company.

2. Is Omkar Pharmachem Ltd undervalued or overvalued?

The key valuation ratios of Omkar Pharmachem Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Omkar Pharmachem Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Omkar Pharmachem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Omkar Pharmachem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Omkar Pharmachem Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -1.3%2.9%-2.6%-4.1%-2.2%0.2%2.8%3.2%2.9%3%-
Value Creation
Index
-1.1-0.8-1.2-1.3-1.2-1.0-0.8-0.8-0.8-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00000.10.30.50.50.50.50
Sales YoY Gr.-NANANANA440%100%0%0%0%-
Adj EPS -0.1-0.1-0.3-0.4-0.30.20.20.20.20.20.2
YoY Gr.-NANANANANA-18.2%11.1%-5%5.3%-
BVPS (₹) 9.19.39.18.68.48.68.899.29.49.4
Adj Net
Profit
-0.1-0.1-0.3-0.4-0.30.20.20.20.20.20
Cash Flow from Ops. 0.3-0.8-0.3-0.3-0.200.20.30.30.2-
Debt/CF from Ops. 00-1-1.9-4.140.34.62.310.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA61%0%0%
Adj EPS NANA3.6%5.3%
BVPS0.3%2.3%2.2%2.2%
Share Price 16.7% 8.3% 6% -2.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-1.3-1.3-2.8-4.7-32.62.12.22.12.21.9
Op. Profit
Mgn %
0000-454.28.149.857.652.653.9NAN
Net Profit
Mgn %
0000-576.98233.936.63537.2INF
Debt to
Equity
0000.10.10.10.10.1000
Working Cap
Days
00007330377182910
Cash Conv.
Cycle
000010-43-18-12-3190

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 1.90%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 3.57%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Omkar Pharmachem Ltd.

Standalone Consolidated
TTM EPS (₹) 0.2 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 9.4 -
Reserves (₹ Cr.) -1 -
P/BV 3.02 -
PE 161.41 -
From the Market
52 Week Low / High (₹) 25.50 / 30.09
All Time Low / High (₹) 1.50 / 30.09
Market Cap (₹ Cr.) 28.6
Equity (₹ Cr.) 10.1
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Omkar Pharmachem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Omkar Pharmachem - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Omkar Pharmachem

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales00000.050.270.540.540.540.54
Operating Expenses 0.120.220.240.380.250.250.270.230.260.25
Manufacturing Costs0000000000
Material Costs0000000000
Employee Cost 0.030.140.140.190.150.150.170.140.160.16
Other Costs 0.090.080.100.190.100.100.100.090.100.09
Operating Profit -0.12-0.22-0.24-0.38-0.200.020.270.310.280.29
Operating Profit Margin (%) -----454.0%8.1%49.8%57.6%52.6%53.9%
Other Income 00.0100000000
Interest 000.010.040.050.060.060.050.030.02
Depreciation 0000000000.01
Exceptional Items 00.4800000000
Profit Before Tax -0.120.27-0.25-0.42-0.26-0.040.210.260.250.27
Tax 00.050-00-0.260.030.070.060.07
Profit After Tax -0.120.22-0.26-0.42-0.260.220.180.200.190.20
PAT Margin (%) -----576.0%82.0%33.9%36.6%35.0%37.2%
Adjusted EPS (₹)-0.10.2-0.3-0.4-0.30.20.20.20.20.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 9.169.389.128.708.448.668.859.049.239.43
Share Capital 10.0810.0810.0810.0810.0810.0810.0810.0810.0810.08
Reserves -0.93-0.71-0.96-1.38-1.64-1.42-1.24-1.04-0.85-0.65
Minority Interest0000000000
Debt000.240.580.870.900.930.620.300.12
Long Term Debt0000000000
Short Term Debt000.240.580.870.900.930.620.300.12
Trade Payables0.040.030.020.020.030.030.020.040.020.01
Others Liabilities 0.520.020.020.020.02-0.22-0.20-0.14-0.060.01
Total Liabilities 9.729.439.409.329.369.379.609.579.499.57

Fixed Assets

Gross Block0.010.010.010.010.010.010.020.020.030.03
Accumulated Depreciation0000.010.010.010.010.020.020.03
Net Fixed Assets 0.0100.010000.0100.010.01
CWIP 0000000000
Investments 9.309.309.309.309.309.309.309.309.309.30
Inventories0000000000
Trade Receivables0.070.070.0700.020.030.080.130.050.10
Cash Equivalents 0.330.050.020.020.040.040.210.130.070.11
Others Assets 0000-00000.060.06
Total Assets 9.729.439.409.329.369.379.609.579.499.57

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.34-0.77-0.25-0.30-0.210.020.200.280.300.24
PBT -0.12-0.21-0.25-0.42-0.26-0.040.210.260.250.27
Adjustment 0-00.020.120.050.060.060.050.030.02
Changes in Working Capital 0.46-0.51-0.010.01-0.010-0.07-0.040.01-0.05
Tax Paid 0-0.05-00000000
Cash Flow From Investing Activity 00.49-0.010-00-0.010-0.01-0
Capex 00.49-0.010-00-0.010-0.01-0
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity -0.010.010.230.300.24-0.02-0.03-0.35-0.35-0.20
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 00.01-0.01-0.04-0.05-0.06-0.06-0.05-0.03-0.02
Dividend Paid 0000000000
Others -0.0100.240.340.290.040.03-0.31-0.32-0.18
Net Cash Flow 0.33-0.28-0.0300.0200.17-0.08-0.060.04

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-1.272.38-2.77-4.72-3.032.592.092.212.072.15
ROCE (%)-1.272.91-2.55-4.11-2.220.222.763.22.943.02
Asset Turnover Ratio000000.030.060.060.060.06
PAT to CFO Conversion(x)N/A-3.5N/AN/AN/A0.091.111.41.581.2
Working Capital Days
Receivable Days00001463037716049
Inventory Days0000000000
Payable Days0000000000

Omkar Pharmachem Ltd Stock News

Omkar Pharmachem Ltd FAQs

The current trading price of Omkar Pharmachem on 20-Oct-2025 16:59 is ₹28.33.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Oct-2025 the market cap of Omkar Pharmachem stood at ₹28.57.
The latest P/E ratio of Omkar Pharmachem as of 19-Oct-2025 is 161.4.
The latest P/B ratio of Omkar Pharmachem as of 19-Oct-2025 is 3.02.
The 52-week high of Omkar Pharmachem is ₹30.09 and the 52-week low is ₹25.50.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Omkar Pharmachem is ₹0.00 ( Cr.) .

About Omkar Pharmachem Ltd

Omkar Pharmachem was incorporated in 1994, it is located in New Delhi. The manufacturing unit developed the capacity to manufacture sodium bi-sulphite, sodium meta bi-sulphite, sodium sulphite, and sulphur.

In the financial year 2007, the company did not conduct any manufacturing or other business activity due to tough market conditions. It has further decided to discontinue commercial activity and wait till an appropriate business environment is established.

The registered office of the company is located at Mahakant Building, 501, Ashram Road opposite V S Hospital Ellisbridge Ahmedabad, Gujarat 380006.

Business area of the company

The company is engaged in the manufacturing of pharmaceutical chemicals.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×